Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN63,9463,981,67
Msft-0,61
Nokia3,55453,7095-1,18
IBM-0,09
Mercedes-Benz Group AG60,1760,190,84
PFE-1,43
17.08.2024 1:38:58
Indexy online
AD Index online
select
AD Index online
 

  • 16.08.2024 22:00:00
Cheesecake (CAKE.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
37,19 -0,03 -0,01 590 048
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: The Cheesecake Factory Incorporated is an experiential dining company focused on hospitality. The Company owns and operates about 334 restaurants throughout the United States and Canada under brands, including The Cheesecake Factory (216 locations), North Italia (37 locations) and a collection within its Fox Restaurant Concepts (FRC) business. The Company's bakery division operates two facilities that produce cheesecakes and other baked products for its restaurants, international licensees, and third-party bakery customers. The Cheesecake Factory menu features about 225 items, exclusive of beverage and dessert items and including items presented on supplemental menus, such as its SkinnyLicious menu that offers items at 590 calories or less. Its menu offerings include appetizers, pizza, seafood, steaks, chicken, burgers, small plates, pastas, salads, sandwiches, and omelets, including a selection of vegan and gluten-free items. It operates 32 Flower Child and 41 other FRC locations.
Financial Summary: BRIEF: For the 26 weeks ended 02 July 2024, Cheesecake Factory Inc revenues increased 4% to $1.8B. Net income increased 21% to $85.6M. Revenues reflect The Cheesecake Factory restaurants segment increase of 3% to $1.34B, North Italia segment increase of 13% to $146.4M, Growth in Guest Counts - % increase of 50% to 1.5%. Net income benefited from The Cheesecake Factory restaurants segment income increase of 14% to $187.1M.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerWolfgang Wienand5201.07.202401.07.2024
Chief Financial Officer, Member of the Executive CommitteePhilippe Deecke5101.12.202101.12.2021
Chief Human Resource Officer, Member of the Executive CommitteeUlrike Kaeppler59
President - Small Molecules, Member of the Executive CommitteeGordon Bates5801.04.2021
President - Biologics, Member of the Executive CommitteeJean-Christophe Hyvert50
Member of the Executive Committee, Head, Group OperationsMaria Nunez5401.08.202201.08.2022
Member of the Executive Committee, President, Cell & GeneDaniel Palmacci5401.11.202201.11.2022
Member of the Executive Committee, President, Capsules & Health Ingredients DivisionChristian Seufert4801.07.202201.07.2022